湖南海利化工股份有限公司第十届五次监事会会议于 2023 年 8 月 15 日以 书面、传真和电子邮件的方式发出会议通知，于 2023 年 8 月 25 日上午在长沙市 公司本部采用现场表决方式召开。会议应到监事 3 人，实到监事 3 人，会议由监 事会主席李一辉先生主持。会议的召集、召开和表决程序符合《公司法》和《公 司章程》的规定。 二、监事会会议审议情况 与会监事经认真讨论并以记名投票方式表决，审议通过以下议案： 证券代码：600731 证券简称：湖南海利 公告编号： 2023－033 湖南海利化工股份有限公司 第十届五次监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 监事会会议召开情况 一、审议通过了《公司 2023 年半年度报告》（全文和摘要） 表决情况：同意 3 票；弃权 0 票；反对 0 票。 《公司 2023 年半年度报告》具体内容同日刊登在《中国证券报》、《上海 证 券 报 》 、 《 证 券 时 报 》 、 《 证 券 日 报 》 及 上 海 证 券 交 易 所 网 站 （http:/ ...

招商证券股份有限公司 关于湖南海利化工股份有限公司 非公开发行股票限售股解禁上市流通的核查意见 招商证券股份有限公司（以下简称"招商证券"、"保荐机构"）作为湖南海 利化工股份有限公司（以下简称"湖南海利"、"公司"）2022年度非公开发行股票 的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所股票上 市规则》和《上海证券交易所上市公司自律监管指引第11号——持续督导》等相关 法律法规的要求，对湖南海利非公开发行股票限售股解禁上市流通事项进行了 审慎核查，具体核查情况及核查意见如下： 一、本次限售股上市类型 湖南海利本次上市流通的限售股类型为非公开发行限售股。 二、本次解禁限售股的基本情况 （一）非公开发行核准情况 2022年11月10日，公司收到中国证券监督管理委员会《关于核准湖南海利 化工股份有限公司非公开发行股票的批复》（证监许可〔2022〕2671号），核 准公司非公开发行不超过138,536,852股新股，核准日期为2022年11月4日，有效 期12个月。 （二）股份登记及限售安排 公司本次发行新增股份的登记托管手续于2023年2月16日在中国证券登记结 算有限责任公司上海分公司办理完 ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-031 湖南海利化工股份有限公司 非公开发行限售股票上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （一）非公开发行核准情况 2022 年 11 月 10 日，公司收到中国证券监督管理委员会《关于核准湖南海利 化工股份有限公司非公开发行股票的批复》（证监许可〔2022〕2671 号），核准公 司非公开发行不超过 138,536,852 股新股，核准日期为 2022 年 11 月 4 日，有效 期 12 个月。（详情请见公司于 2022 年 11 月 11 日披露的《湖南海利化工股份有限 公司关于非公开发行 A 股股票申请获得中国证监会核准批复的公告》，编号： 2022-061）。 （二）股份登记时间 公司本次发行新增股份的登记托管手续于 2023 年 2 月 16 日在中国证券登记 结算有限责任公司上海分公司办理完成。具体情况详见公司于 2023 年 2 月 18 日 在上海证券交易所网站（www.sse.com.cn）披露的《湖 ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-026 湖南海利化工股份有限公司 关于召开 2022 年度业绩暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 投资者可于 2023 年 05 月 05 日(星期五) 至 05 月 11 日(星期四)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 sh600731@sina.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 湖南海利化工股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日发 布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况，公司计划于 2023 年 05 月 12 日下午 15:00-16:00 举行 2022 年度业绩暨现金分红说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通， ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥590,720,878.11, a decrease of 2.78% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥85,277,322.24, representing a year-on-year increase of 29.25%[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥82,860,371.71, up 34.74% year-on-year[6]. - Basic and diluted earnings per share were both ¥0.1620, reflecting a 13.38% increase compared to the previous year[6]. - Net profit for Q1 2023 increased by 27.00% to ¥84,444,969.15 compared to ¥66,497,475.56 in Q1 2022[20]. - The company reported a total comprehensive income of ¥84,444,969.15 for Q1 2023, compared to ¥66,497,475.56 in Q1 2022, indicating a year-over-year increase of 27.00%[21]. Cash Flow - The net cash flow from operating activities was ¥58,592,906.66, a significant improvement from a negative cash flow of ¥11,378,087.82 in the same period last year[6]. - Cash flow from operating activities generated a net amount of ¥58,592,906.66 in Q1 2023, a turnaround from a net outflow of ¥15,369,089.14 in Q1 2022[24]. - Cash inflow from financing activities in Q1 2023 was ¥729,806,907.29, significantly higher than ¥339,276,492.15 in Q1 2022[24]. - The net increase in cash and cash equivalents for Q1 2023 was $598.05 million, compared to $86.94 million in Q1 2022, reflecting a substantial rise of approximately 588%[25]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥4,524,125,841.17, an increase of 15.25% from the end of the previous year[6]. - The company's current assets totaled RMB 2,692,850,567.50, up from RMB 2,145,278,210.14, indicating an increase of about 25.6% year-over-year[17]. - Cash and cash equivalents reached RMB 1,407,241,970.58, compared to RMB 769,342,388.41 at the end of 2022, reflecting an increase of approximately 82.8%[16]. - The total liabilities decreased to RMB 1,558,366,857.68 from RMB 1,732,031,231.59, showing a reduction of about 10.0%[18]. - The company’s total liabilities and equity increased to ¥4,524,125,841.17 in Q1 2023 from ¥3,925,429,646.80 in Q1 2022[19]. Shareholder Information - Equity attributable to shareholders was ¥2,818,939,806.73, marking a 37.79% increase year-on-year[6]. - The total number of ordinary shareholders at the end of the reporting period was 25,539[12]. - The company's equity attributable to shareholders rose to RMB 2,818,939,806.73, up from RMB 2,045,866,835.50, marking an increase of approximately 37.8%[18]. Research and Development - Research and development expenses rose significantly by 71.95% to ¥30,825,402.00 in Q1 2023 from ¥17,907,713.77 in Q1 2022[19]. Non-Recurring Gains - The company reported non-recurring gains of ¥2,416,950.53 for the current period, with government subsidies contributing significantly to this figure[10].

Financial Performance - In 2022, the company achieved a net profit attributable to shareholders of RMB 352,269,305.76, with an undistributed profit at the end of the year amounting to RMB 855,970,798.26[5]. - The company's operating revenue for 2022 reached ¥3,130,113,836, representing a 13.89% increase compared to ¥2,748,472,985.8 in 2021[24]. - Net profit attributable to shareholders for 2022 was ¥352,269,305.76, a 32.10% increase from ¥266,678,700.06 in 2021[24]. - Basic earnings per share for 2022 were ¥0.7628, up 32.09% from ¥0.5775 in 2021[27]. - The total assets of the company increased by 18.79% to ¥3,925,429,646 in 2022 from ¥3,304,559,232.6 in 2021[26]. - The weighted average return on equity for 2022 was 18.65%, an increase of 2.44 percentage points from 16.21% in 2021[27]. - The company's net assets attributable to shareholders increased by 19.03% to ¥2,045,866,835 at the end of 2022 from ¥1,718,721,922.5 at the end of 2021[24]. - The company achieved an operating revenue of 3.13 billion yuan and a net profit attributable to the parent company of 352 million yuan in 2022[37]. - The company reported a net cash flow from operating activities of CNY 249,085,632.49, a 113.50% increase from the previous year, highlighting improved cash generation[55]. Investment and Capital Management - The company decided not to distribute profits or increase capital reserves for the year 2022, prioritizing funding for ongoing projects and research and development[5]. - The company is currently in a phase requiring significant capital investment due to the construction of key projects such as the Ningxia production base and the new base in Guixi[5]. - The company plans to raise up to 700 million yuan through a non-public stock issuance to support the construction of production bases[42]. - The company has not proposed any changes to its share capital structure for the year 2022[5]. - The company’s retained earnings will be used to support project construction and R&D investments, ensuring stable operations and healthy development[183]. Research and Development - The company’s research and development investment reached approximately 146 million yuan, with an R&D intensity of 4.6%, representing a 39.67% increase from the previous year[41]. - The company has applied for 19 invention patents during the reporting period, with a total of 23 authorized invention patents[41]. - The total R&D expenditure amounted to ¥145,941,302.08, representing 4.66% of total revenue[65]. - The company has developed over 100 new high-efficiency, low-risk pesticide compounds, with two insecticides and one fungicide being part of the national "13th Five-Year Plan" key research projects[84]. - The company is focusing on the development of new technologies and products, particularly in the agricultural sector, to enhance competitiveness and meet environmental standards[104]. Market Performance and Sales - Revenue from the agricultural pesticide segment reached ¥2,040,053,521.76, with a year-over-year increase of 11.81%[57]. - Lithium battery segment revenue was ¥500,531,238.73, showing a significant decrease of 77.56% year-over-year[57]. - Revenue from the overseas market was ¥1,425,148,480.06, reflecting a year-over-year increase of 51.19%[59]. - The company is actively expanding overseas markets for its agricultural products, achieving record sales in the agricultural chemical sector[39]. - The company’s sales revenue from Hailey Lithium Battery approached 500 million yuan during the reporting period[39]. Risk Management - The company faces various risks including policy, market, operational, and financial risks, which are discussed in detail in the management analysis section[9]. - The company has established a risk management framework to address credit, liquidity, and market risks associated with financial instruments[124]. - The company faces policy risks due to increasing regulatory requirements in the agricultural chemical industry, which may impact production capabilities and product compliance[113]. - The company has implemented comprehensive environmental protection measures, but faces risks of penalties if unable to meet stricter future regulations[115]. - Fluctuations in raw material prices directly affect production costs and profit margins, posing a risk to operational stability[120]. Corporate Governance - The company has received a standard unqualified audit report from Da Hua Accounting Firm[4]. - The board of directors held 11 meetings during the year, ensuring compliance with legal and regulatory requirements[135]. - The supervisory board conducted 8 meetings in 2022, maintaining compliance with relevant laws and regulations[136]. - The company has implemented performance evaluation standards and incentive mechanisms for directors, supervisors, and senior management[137]. - The company is committed to transparency in its financial reporting and governance practices, ensuring compliance with relevant regulations[140]. Employee Management - The company reported a total of 1,979 employees, with 1,875 in major subsidiaries and 104 in the parent company[175]. - The employee composition includes 934 production personnel, 112 sales personnel, 352 technical personnel, 62 financial personnel, and 291 administrative personnel[177]. - The company has implemented a multi-level compensation incentive policy, linking employee salaries closely to company performance and individual achievements[178]. - In 2022, the company organized various training programs, including safety training and modern enterprise management training, to enhance employee skills[179]. - The company plans to conduct more comprehensive talent development programs in 2023 to improve human resource capabilities[179]. Future Outlook - The company plans to strengthen its core businesses and research institutions while focusing on green industrial development and efficient project construction[106]. - The company aims to enhance competitiveness through a strategy focused on "industrial scale, product diversification, green production, international operations, precise services, and scientific management" to achieve high-quality development[105]. - The company is exploring market expansion opportunities, particularly in Southeast Asia, as production capacities shift from developed countries[104]. - The company has set ambitious performance guidance for the next fiscal year, aiming for a substantial increase in revenue[148]. - The company provided a future outlook, projecting a revenue growth of 10% for the next fiscal year[151].

2022 年第三季度报告 证券代码：600731 证券简称：湖南海利 湖南海利化工股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人董事长刘卫东、总经理（法定代表人）尹霖、主管会计工作负责人蒋祖学及会计机构 负责人（会计主管人员）宁建文保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | | 上年同期 | 本报告 期比上 年同期 增减变 | 年初至报 告期末 | 上年同期 | | 年初至报 告期末比 上年同期 增减变动 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 动幅度 | | | | | | | ...

Financial Performance - The company's operating revenue for the first half of 2022 reached ¥1,413,473,060.16, representing a 17.11% increase compared to ¥1,206,955,262.51 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was ¥185,067,625.37, a 35.20% increase from ¥136,887,674.26 in the previous year[21]. - Basic earnings per share for the first half of 2022 were ¥0.40076, up 35.20% from ¥0.29643 in the same period last year[24]. - The company achieved a total operating revenue of CNY 1.413 billion and a net profit attributable to the parent company of CNY 185 million in the first half of 2022[42]. - Net profit for the first half of 2022 was ¥191,365,402.85, representing a 37.0% increase from ¥139,666,780.52 in the first half of 2021[178]. - The company reported a significant increase in other income, which rose to ¥2,476,871.83 from ¥638,314.70, marking a growth of 287.5%[176]. Assets and Liabilities - The total assets of the company as of June 30, 2022, were ¥3,752,599,394.49, reflecting a 15.64% increase from ¥3,245,037,226.62 at the end of the previous year[23]. - The net assets attributable to shareholders of the listed company increased to ¥1,887,732,114.37, a 10.44% increase from ¥1,709,241,890.85 at the end of the previous year[23]. - The total liabilities as of the reporting date were ¥1,458,778,958.13, compared to ¥1,050,241,703.41 at the end of the previous period, indicating a rise of 38.9%[173]. - The company's total liabilities reached CNY 1,734,722,028.87, compared to CNY 1,360,575,418.80 at the beginning of the period, reflecting a growth of approximately 27.5%[168]. Cash Flow - The company reported a net cash flow from operating activities of -¥42,093,127.42, a decline from a positive cash flow of ¥3,713,441.48 in the previous year[47]. - Cash flow from financing activities generated a net inflow of CNY 208,126,187.18, compared to CNY 86,642,253.72 in the first half of 2021, reflecting a substantial increase[190]. - The cash outflow from operating activities was CNY 1,160,177,401.63, resulting in a net cash flow from operating activities of CNY -42,093,127.42, a decline from CNY 3,713,441.48 in the first half of 2021[188]. Research and Development - The company is actively involved in 22 various R&D projects, including 13 at the municipal level or above, demonstrating its commitment to innovation[45]. - Research and development expenses increased significantly by 80.84% to ¥66,791,116.04 from ¥36,933,974.34, indicating a strong commitment to innovation[47]. - The company acquired 100% equity of Hunan Chemical Research Institute, enhancing its research and development capabilities and achieving integration of production and research[36]. Market Position and Competition - The company achieved a sales ranking of 39th in the national pesticide industry for 2022, improving from the previous year, with sales growth exceeding 16% compared to 2021[33]. - The company is recognized as one of the top ten domestic producers of manganese lithium cathode materials, with a strong market presence and influence in production capacity, product quality, and cost efficiency[33]. - The company is exposed to market competition risks due to a large number of domestic pesticide manufacturers and increasing international competition[64]. Environmental Compliance - The company has implemented measures to ensure compliance with environmental regulations, which is critical for sustainable operations in the pesticide industry[62]. - The company has established an ISO14001 environmental management system and has obtained environmental pollution liability insurance for 2021[117]. - The company has implemented a systematic monitoring approach for its main pollutants as required by local environmental management authorities[95]. Risk Management - The company has established a risk management framework to address credit, liquidity, and market risks associated with its financial instruments[72]. - The company faces risks from potential changes in environmental protection policies, which could increase operational costs and regulatory compliance burdens[62]. - The company is actively addressing challenges posed by stricter environmental policies and supply chain constraints, demonstrating resilience in a competitive market[33]. Community Engagement - The company is actively involved in rural revitalization efforts, including the establishment of an organic fertilizer plant to increase income for local farmers[126]. - The company has improved public infrastructure in Anan Village, benefiting the local community significantly since 2020[126]. - The company has engaged in talent training programs to support local agricultural development and employment opportunities[126].

Financial Performance - In 2021, the company achieved a net profit attributable to shareholders of RMB 268,402,640.46, with an undistributed profit at the end of the year amounting to RMB 540,596,397.88[5]. - The company's operating revenue for 2021 was CNY 2,702,324,118, representing a 23.79% increase compared to CNY 2,183,017,101 in 2020[23]. - The net profit attributable to shareholders for 2021 was CNY 268,402,640, a decrease of 9.44% from CNY 296,395,378 in 2020[23]. - The cash flow from operating activities for 2021 was CNY 121,943,073, down 72.18% from CNY 438,354,074 in 2020[23]. - Basic earnings per share for 2021 were CNY 0.6431, a decline of 22.93% from CNY 0.8344 in 2020[24]. - The weighted average return on equity for 2021 was 16.30%, down 6.17 percentage points from 22.47% in 2020[26]. - The total assets at the end of 2021 were CNY 3,245,037,226.62, a slight increase of 1.63% from CNY 3,193,068,140.29 at the end of 2020[23]. - The company reported a significant decrease in cash flow from financing activities, totaling -¥439,815,164.95[67]. - The company's cash and cash equivalents decreased by 44.02% to ¥471,212,914.31, primarily due to reduced bank loans and increased material procurement payments[69]. - The company reported a total revenue of 23.4 billion with a net profit margin of approximately 3.9%[147]. Risk Management - The company faces various risks including policy, market, operational, and financial risks, which are discussed in detail in the management analysis section[9]. - The company has a comprehensive risk management strategy in place to address potential uncertainties in future operations[9]. - The company is exposed to market competition risks due to the fragmented nature of the pesticide industry and the entry of new domestic and international competitors[115]. - The company faces risks from potential changes in environmental protection policies that could lead to increased operational costs and production limitations[112]. - Raw material supply and price volatility pose significant risks to the company's production costs and gross margins, particularly due to seasonal procurement challenges and increasing demand as production scales up[118]. - The company has established a risk management framework to address various financial risks, including credit, liquidity, and market risks, ensuring regular assessments and updates to its policies[123]. Strategic Initiatives - The board proposed not to distribute profits for 2021 and not to increase capital from the capital reserve, aiming to enhance competitiveness and fund key projects in 2022[5]. - The company is focusing on significant projects in Ningxia and Guixi, which will require substantial capital investment to achieve strategic goals[5]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[30]. - The company aims to enhance competitiveness through a strategy focused on "industrial scale, product diversification, green production, international operations, precise services, and scientific management"[106]. - The company is actively involved in mergers and acquisitions within the agricultural chemical sector, consolidating industry resources[79]. - The company plans to achieve an annual production capacity of 4,000 tons of methamidophos and 5,000 tons of methyl thiophanate at its Ningxia base upon completion[37]. Research and Development - R&D investment accounted for 3.79% of total revenue, with 25 new patent applications and 12 patents granted during the reporting period[36]. - The company has established a strong R&D capability, achieving significant breakthroughs in continuous process technology for several products[36]. - The company is focusing on green product innovation and has over 100 new pesticide compounds under research, with several projects recognized as key national research initiatives[88]. - The company is investing in R&D, allocating 5% of its revenue towards developing new technologies and products[152]. Corporate Governance - The company conducted a governance self-inspection in 2021, addressing issues related to fund occupation by related parties[133]. - The board of directors consists of 9 members, including 3 independent directors, and operated within legal requirements[136]. - The company has not engaged in any related party transactions that would affect its independence[142]. - The company has established a robust internal control management system, continuously optimizing its governance structure and internal control systems based on operational realities, achieving the expected internal control objectives[189]. Environmental Compliance - The company has implemented automatic monitoring for key pollutants, ensuring compliance with environmental standards[198]. - The total COD discharge was 109.698 tons, with a concentration of 74.247 mg/L, below the limit of 135.75 tons/year[198]. - The company processed 5,407.1531 tons of pesticide waste through its own incineration facility[200]. - The company has a total of 1 wastewater discharge outlet, with a pH level of 7, compliant with the standard of 6-9[198]. Market Position - The company ranked 40th among the top 100 pesticide sales in China and 16th in pesticide exports in 2021, with approximately 50% of its products sold internationally[82]. - The company is recognized as a leading enterprise in the domestic carbamate pesticide market, with a high market share[50]. - The company has been awarded multiple national and provincial honors for product quality and innovation, enhancing its brand reputation[52]. Human Resources - The company employed a total of 1,844 staff, with 116 in the parent company and 1,728 in major subsidiaries[172]. - The workforce includes 889 production personnel, 101 sales personnel, 314 technical personnel, 51 financial personnel, and 225 administrative personnel[172]. - The company has established a multi-level compensation incentive policy linking employee salaries to company performance and individual performance[175]. - In 2021, the company organized various training programs, including safety training and modern enterprise management training, to enhance employee skills[176].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 601,107,428.34, representing a year-on-year increase of 20.27%[4] - The net profit attributable to shareholders for the same period was CNY 67,197,288.25, reflecting an increase of 8.40% compared to the previous year[4] - The basic earnings per share (EPS) decreased by 16.61% to CNY 0.1455[5] - Total operating costs for Q1 2022 were CNY 528,140,920.57, an increase of 24.1% compared to CNY 425,537,857.98 in Q1 2021[18] - Net profit for Q1 2022 was CNY 68,147,543.24, representing a 10.9% increase from CNY 61,472,055.25 in Q1 2021[19] - Operating profit for Q1 2022 was CNY 75,624,575.65, slightly up from CNY 75,107,823.19 in the same period last year[18] - The company achieved a total profit of CNY 79,782,011.93 in Q1 2022, compared to CNY 75,416,951.19 in Q1 2021, marking an increase of 4.5%[18] Assets and Liabilities - The total assets at the end of the reporting period amounted to CNY 3,469,732,070.07, an increase of 6.92% from the end of the previous year[5] - Current assets totaled CNY 1,861,432,748.32, an increase of 12.9% from CNY 1,648,509,615.65 in the previous year[14] - Cash and cash equivalents increased to CNY 553,040,359.42 from CNY 471,212,914.31, representing a growth of 17.4%[14] - Total liabilities increased to CNY 1,575,892,951.19 from CNY 1,360,575,418.80, marking a rise of 15.8%[16] - The company's short-term borrowings rose significantly to CNY 200,000,000.00 from CNY 65,000,000.00, indicating a 207.7% increase[16] Cash Flow - The company's cash flow from operating activities was negative at CNY -11,378,087.82, indicating a significant cash outflow[4] - Cash flow from operating activities showed a net outflow of CNY 11,378,087.82, an improvement from a net outflow of CNY 31,381,459.08 in Q1 2021[21] - Cash and cash equivalents at the end of Q1 2022 totaled CNY 517,483,069.19, down from CNY 815,995,772.67 at the end of Q1 2021[22] Inventory and Prepayments - The company's prepayments increased by 38.15%, primarily due to higher payments for raw materials[9] - Inventory levels rose by 39.74%, attributed to an increase in product stock[9] - Inventory levels increased to CNY 444,148,534.51 from CNY 317,839,810.44, reflecting a growth of 39.7%[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 32,795[11] Research and Development - Research and development expenses for Q1 2022 were CNY 17,637,463.12, up from CNY 15,226,706.53 in Q1 2021, indicating a focus on innovation[18] Financial Expenses - The company incurred a financial expense of CNY 3,894,191.42 in Q1 2022, which is significantly higher than CNY 2,059,142.57 in Q1 2021[18] Sales Performance - The company reported a total revenue from sales of goods and services of CNY 524,454,203.29 in Q1 2022, compared to CNY 465,116,936.04 in Q1 2021, reflecting a growth of 12.7%[21]